Study Review – OPERA trials: long-term treatment with ocrelizumab in relapsing multiple sclerosis

As part of our ongoing aim to bring you reports of new developments, we have added a review of a recent study update on the Opera trials with 5 and 7-year data and now an update at 10 years.

Independent commentary for the review has been provided by Clinical Associate Professor Todd Hardy, Senior Staff Specialist Neurologist at Concord Hospital, Clinical Associate Professor in Medicine at the University of Sydney.

 

Please login below to download this issue (PDF)

Subscribe